We have a strong track record in launching new products and line extensions based on a close cooperation between R&D and marketing teams. Our expertise in line extensions and OTC switch has been the key to the remarkable success of brands like Paracet and Ibux, which dominate the Norwegian analgesic market.

Our R&D team has long experience in bringing profitable products to market fulfilling consumer’s needs. We have strong competences in drug formulation and technologies, medical/clinical development, regulatory documentation and manufacturing. We cover pharmaceutical and non-pharmaceutical products, such as food supplements, cosmetics and medical devices. Our innovation process facilitates the conceptualisation of product ideas through to projects and project execution.

An extensive network of partners contributes across the different stages of product development, including several contract research organisations (CRO).

For further information please contact:

Astrid T. Bratvedt, CSO